Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Epidemiology of cardiovascular disease in China: current features and implicationsNature reviews cardiology, 2019-04, Vol.16 (4), p.203-212 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2019 ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-018-0119-4 ;PMID: 30467329Full text available |
|
2 |
Material Type: Article
|
2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEuropean journal of preventive cardiology, 2022-02, Vol.29 (1), p.5 [Peer Reviewed Journal]ISSN: 2047-4881 ;EISSN: 2047-4881 ;DOI: 10.1093/eurjpc/zwab154 ;PMID: 34558602Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular HealthCurrent nutrition reports, 2018-12, Vol.7 (4), p.198-206 [Peer Reviewed Journal]The Author(s) 2018 ;EISSN: 2161-3311 ;DOI: 10.1007/s13668-018-0248-8 ;PMID: 30264354Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Effects of n−3 Fatty Acid Supplements in Diabetes MellitusThe New England journal of medicine, 2018-10, Vol.379 (16), p.1540-1550 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804989 ;PMID: 30146932Full text available |
|
5 |
Material Type: Article
|
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesThe New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978Full text available |
|
6 |
Material Type: Article
|
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME TrialDiabetes care, 2018-02, Vol.41 (2), p.356-363 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1096 ;PMID: 29203583Full text available |
|
7 |
Material Type: Article
|
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction: An Individual Participant Meta-Analysis of Prospective Observational Data From 17,635 SubjectsJournal of the American College of Cardiology, 2014-02, Vol.63 (7), p.636-646 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 25, 2014 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.09.063 ;PMID: 24239664 ;CODEN: JACCDIFull text available |
|
8 |
Material Type: Article
|
CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countriesCardiovascular diabetology, 2021-07, Vol.20 (1), p.154-154, Article 154 [Peer Reviewed Journal]2021. The Author(s). ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2021 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-021-01344-0 ;PMID: 34315481Full text available |
|
9 |
Material Type: Article
|
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-upDiabetes care, 2016-05, Vol.39 (5), p.686-693 [Peer Reviewed Journal]2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association May 2016 ;2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2016 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-1990 ;PMID: 26861924 ;CODEN: DICAD2Full text available |
|
10 |
Material Type: Article
|
Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-upThe New England journal of medicine, 2019-06, Vol.380 (23), p.2215-2224 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806802 ;PMID: 31167051Full text available |
|
11 |
Material Type: Article
|
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 DiabetesThe New England journal of medicine, 2013-07, Vol.369 (2), p.145-154 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1212914 ;PMID: 23796131 ;CODEN: NEJMAGFull text available |
|
12 |
Material Type: Article
|
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational studyDiabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.3442017 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13077 ;PMID: 28771923Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyDiabetes care, 2017-12, Vol.40 (12), p.1756-1762 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Dec 2017 ;2017 by the American Diabetes Association. 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-2523 ;PMID: 29138273Full text available |
|
14 |
Material Type: Article
|
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 DiabetesThe New England journal of medicine, 2015-06, Vol.372 (23), p.2197-2206 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414266 ;PMID: 26039600Full text available |
|
15 |
Material Type: Article
|
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 DiabetesThe New England journal of medicine, 2021-12, Vol.385 (24), p.2252-2263 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2110956 ;PMID: 34449181Full text available |
|
16 |
Material Type: Article
|
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutideDiabetes, obesity & metabolism, 2018-01, Vol.20 (1), p.422017 John Wiley & Sons Ltd. ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13028 ;PMID: 28573765Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialThe Lancet (British edition), 2019-07, Vol.394 (10193), p.121-130 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31149-3 ;PMID: 31189511Full text available |
|
18 |
Material Type: Article
|
Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic ConcernsMolecules (Basel, Switzerland), 2021-06, Vol.26 (13), p.4021 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules26134021 ;PMID: 34209338Full text available |
|
19 |
Material Type: Article
|
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) PandemicTrends in cardiovascular medicine, 2020-08, Vol.30 (6), p.315 [Peer Reviewed Journal]Copyright © 2020. Published by Elsevier Inc. ;Copyright Elsevier Limited Aug 2020 ;ISSN: 1050-1738 ;EISSN: 1873-2615 ;DOI: 10.1016/j.tcm.2020.05.004 ;PMID: 32474135Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic ReviewValue in health, 2018-07, Vol.21 (7), p.881 [Peer Reviewed Journal]Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. ;EISSN: 1524-4733 ;DOI: 10.1016/j.jval.2017.12.019 ;PMID: 30005761Digital Resources/Online E-Resources |